XML 107 R87.htm IDEA: XBRL DOCUMENT v3.25.1
FINANCIAL INSTRUMENTS AND RISK MANAGEMENT (Tables)
12 Months Ended
Dec. 31, 2024
FINANCIAL INSTRUMENTS AND RISK MANAGEMENT  
Measurement of financial leveraging index

12/31/2023

 

    

12/31/2024

    

Reclassified

Total loans, financing and debentures

 

75,620,574

 

59,460,369

(+) Derivative financial instruments - debt protection

 

(974,381)

 

657,514

(-) Marketable securities

 

(9,385,179)

 

(6,352,895)

(-) Cash and cash equivalents

 

(26,572,522)

 

(13,046,371)

Net debt

 

38,688,492

 

40,718,617

(+) Total shareholders’ equity

 

121,999,776

 

112,464,644

Total capital

160,688,268

153,183,261

Financial leverage index

24

27

The accounting balances of financial assets and liabilities represent a reasonable approximation of fair value

12/31/2023

    

Level

    

12/31/2024

    

Reclassified

FINANCIAL ASSETS

 

  

 

  

 

  

Amortized cost

 

 

39,017,827

 

24,673,081

Cash and cash equivalents

26,572,522

13,046,371

Accounts receivable, net

 

 

6,513,888

 

5,859,928

Restricted cash

3,679,483

2,772,947

Reimbursement rights

 

 

1,613,335

 

2,365,685

Loans, financing and debentures

 

 

638,599

 

628,150

Fair value through result

 

 

11,537,109

 

6,726,501

Financial investments

 

2

 

8,967,937

 

5,925,693

Beneficiary parties

2

417,242

427,202

Derivative financial instruments

 

2

 

2,151,930

 

373,606

Fair value through other comprehensive income

 

946,059

1,104,381

Investments (Interests)

1

 

861,234

1,104,381

Derivative financial instruments

2

84,825

FINANCIAL LIABILITIES

  

 

  

 

  

Amortized cost

 

109,460,695

 

100,988,575

Loans, financing and debentures

 

59,297,533

 

54,299,620

Obligations of Law No. 14,182/2021

42,022,123

39,519,406

Suppliers

 

2,764,288

 

2,963,867

Compulsory loan – Agreements

 

1,105,534

 

896,746

RGR Returns

932,250

1,319,921

Reimbursement obligations

70,803

Shareholders compensation

 

2,490,668

 

1,154,836

Leases

 

182,583

 

216,747

Concessions payable - use of public property

594,913

617,432

Fair value through result

 

 

17,500,976

 

7,138,184

Loans, financing and debentures

2

16,323,041

6,480,670

Derivative financial instruments

 

2

 

1,177,935

 

657,514

Schedule of analysis of non-derivative financial liabilities by maturity

12/31/2024

Nominal payment flow

Up to 1 year

    

From 1 to 2 Years

    

From 2 to 5 Years

    

Over 5 Years

    

Total

FINANCIAL LIABILITIES (Current / Non-Current)

 

22,599,741

 

22,968,512

 

41,394,062

 

97,366,345

 

184,328,660

Obligations of Law No. 14,182/2021

2,953,184

3,439,353

12,906,745

62,908,147

82,207,429

Loans, financing and debentures

 

13,769,529

 

18,913,993

 

28,317,110

 

34,133,371

 

95,134,002

Suppliers

2,756,329

7,959

2,764,288

RGR Returns

 

492,276

 

439,974

 

 

 

932,250

Reimbursement Obligations

55,517

15,286

70,803

Shareholders remuneration

2,490,668

2,490,668

Leases

 

31,192

 

20,183

 

29,536

 

41,971

 

122,882

Concessions payable UBP

 

51,046

 

131,764

 

140,671

 

282,856

 

606,337

12/31/2023

Nominal payment flow

    

Up to 1 year

    

From 1 to 2 Years

    

From 2 to 5 Years

    

Over 5 Years

    

Total

FINANCIAL LIABILITIES (Current / Non-Current)

 

23,534,123

 

16,402,453

 

37,162,840

 

86,456,689

 

163,556,105

Obligations of Law No. 14,182/2021

 

2,196,092

 

2,832,052

 

11,675,962

 

64,112,911

 

80,817,017

Loans, financing and debentures

16,303,004

12,806,056

24,871,962

21,856,170

75,837,192

Suppliers

 

2,963,867

 

 

 

 

2,963,867

RGR Returns

439,974

439,974

439,974

1,319,922

Reimbursement Obligations

8,572

8,572

Shareholders remuneration

1,522,866

1,522,866

Leases

 

48,482

 

75,682

 

49,138

 

66,936

 

240,238

Concessions payable UBP

 

51,266

 

248,689

 

125,804

 

420,672

 

846,431

Schedule of derivative financial instruments

    

12/31/2024

    

12/31/2023

    

12/31/2024

    

12/31/2023

Maturity

    

Notional value

    

Assets

Liability

Debt protection derivative

 

  

 

  

Swap - US$ vs CDI

 

1/8/2025

493,000

118,733

 

Swap - US$ vs CDI

 

2/4/2025

2,535,300

500,998

 

220,165

Swap - US$ vs CDI

 

8/29/2025

219,150

54,290

 

8,611

Swap - US$ vs CDI

 

12/9/2025

500,000

13,170

 

Swap - EUR vs CDI

12/23/2025

500,000

5,245

Swap - US$ vs CDI

6/20/2029

232,873

47,415

7,603

3,601

Swap - US$ vs CDI

2/4/2030

3,782,873

715,544

235,194

425,137

Swap - IPCA vs CDI

9/15/2034

1,630,000

89,867

Swap - US$ vs CDI

12/4/2034

2,378,400

266,397

185,005

Swap - US$ vs CDI

1/11/2035

4,229,025

287,736

316,342

Swap - IPCA vs CDI

6/15/2031

4,900,000

142,788

343,924

2,152,316

1,177,935

657,514

Long-term commitment derivatives

NDF US$

4/30/2025

67,113

224

NDF US$ and primary aluminum

12/2/2025

1,342

274

NDF US$ and primary aluminum

8/3/2026

156,583

30,129

NDF US$ and primary aluminum

9/1/2026

60,175

11,780

NDF US$ and primary aluminum

9/2/2026

210,668

42,032

84,439

2,236,755

1,177,935

657,514

    

    

12/31/2024

    

12/31/2023

Variation of fair value of the derivative

Swap - US$ vs CDI

 

1/8/2025

 

109,356

 

Swap - US$ vs CDI

 

4/2/2025

 

560,392

 

(275,755)

Swap - US$ vs CDI

 

8/29/2025

 

52,930

 

(8,610)

Swap - US$ vs CDI

 

12/9/2025

 

13,170

 

Swap - EUR vs CDI

12/23/2025

5,245

Swap - US$ vs CDI

18/06/2026

68,485

Swap - US$ vs CDI

6/20/2029

41,141

(6,373)

Swap - US$ vs CDI

2/4/2030

634,410

(512,050)

Swap - IPCA vs CDI

6/15/2031

(296,800)

Swap - IPCA vs CDI

9/15/2034

(89,867)

Swap - US$ vs CDI

12/4/2034

81,392

Swap - US$ vs CDI

1/11/2035

(28,606)

Variation of fair value of the protected debt

 

 

 

Bonds

2/4/2025

(765,876)

49,395

Bonds

 

2/4/2030

 

(1,068,243)

 

(129,796)

Bonds

 

1/11/2035

 

(95,074)

 

Credit agreement

 

1/8/2025

 

(165,382)

 

Credit agreement

 

8/29/2025

 

(68,059)

 

(15,503)

Credit agreement

 

12/9/2025

 

(17,497)

 

Credit agreement

6/18/2026

(257,569)

CGT ESUL EURO

12/23/2025

(7,838)

KFW

6/20/2029

(59,203)

(9,689)

Debentures

6/15/2031

(53,596)

Debentures

9/15/2034

46,824

SPA (SACE)

12/4/2034

(206,217)

Net financial result

 

 

(1,566,482)

 

(908,381)

Schedule of derivatives changes

    

2024

    

2023

Balance on January 1

(283,908)

986,862

Fair value assessment - result

 

1,151,248

 

(1,416,044)

Fair value assessment - OCI

 

84,825

 

Amortizations

 

106,655

 

145,274

Balance as of December 31st

 

1,058,820

 

(283,908)

Assets

 

2,236,755

 

373,606

Liabilities

 

1,177,935

 

657,514

Interest rate appreciation risk  
FINANCIAL INSTRUMENTS AND RISK MANAGEMENT  
Impact of each scenario on company results, sensitivity analysis

Effect on result

Balance on

Scenario I -

Scenario II

Scenario III 

    

12/31/2024

    

Probable 20251

    

(+25%)1

    

(+50%)1

CDI

Loans, financing and debentures

(44,428,113)

(6,619,789)

(8,276,957)

(9,929,683)

Financing and loans receivable

450,000

67,050

83,835

100,575

Impact on the result

(43,978,113)

(6,552,739)

(8,193,122)

(9,829,108)

SELIC

Loans, financing and debentures

(114,955)

(17,243)

(21,554)

(25,865)

AIC Reimbursement

112,816

16,922

21,153

25,384

Impact on the result

(2,139)

(321)

(401)

(481)

TJLP

Loans, financing and debentures

(2,873,003)

(251,100)

(314,019)

(376,651)

Impact on the result

(2,873,003)

(251,100)

(314,019)

(376,651)

IGPM (General Market Price Index)

Leases

(182,583)

(8,618)

(10,772)

(12,927)

Impact on the result

(182,583)

(8,618)

(10,772)

(12,927)

Obligations of Law No. 14,182/2021

(42,022,123)

(2,252,386)

(2,815,482)

(3,378,579)

IPCA

Loans, financing and debentures

(26,215,920)

(1,405,173)

(1,756,467)

(2,107,760)

Right of reimbursement

1,500,519

80,428

100,535

120,642

Financing and loans receivable

502,585

26,939

33,673

40,408

Impact on the result

(66,234,939)

(3,550,192)

(4,437,741)

(5,325,289)

Impact on profit or loss in case of assessment of national indexes

(10,362,970)

(12,956,055)

(15,544,456)

(1) Assumptions adopted:

12/31/2024

Likely

+25%

+50%

CDI

12.15

14.90

18.63

22.35

SELIC

12.25

15.00

18.75

22.50

TJLP

7.43

8.74

10.93

13.11

IGPM (General Market Price Index)

6.54

4.72

5.90

7.08

IPCA

4.89

5.36

6.70

8.04